Publications by authors named "Charles Argoff"

Claim this Profile
V
VER-01 Shows Enhanced Gastrointestinal Tolerability, Superior Pain Relief, and Improved Sleep Quality Compared to Opioids in Treating Chronic Low Back Pain: A Randomized Phase 3 Clinical Trial.
Winfried Meissner, Charles Argoff, Sabine Sator, Volker Schoder, Matthias Karst

Pain Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Therapeutic Potential of Dual NMR (NOP/MOP) Agonism in Pain Management.
Roberto Ciccocioppo, Jeffrey Gudin, Charles E Argoff, Emanuela Offidani, James Hackworth

Pain Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Wang et al.'s Reply to "Notable concerns in methodology and conclusions of the Wang et al. Meta-analysis in BMJ by the American Academy of Pain Medicine" by Schuster et al.
Nathaniel M Schuster, Mustafa Broachwala, Farshad M Ahadian, Charles E Argoff, Steven P Cohen

Pain Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine.
Fawad A Khan, Steven P Herzog, Ryan M Smith, Dawn C Buse, Seema Soni-Brahmbhatt, Charles Argoff

J Headache Pain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog.
Charles Argoff, Fawad A Khan, Steven P Herzog, Ryan M Smith, Seema Soni-Brahmbhatt

J Headache Pain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum clinically important differences in acute pain: a patient-level re-analysis of randomized controlled analgesic trials submitted to the US Food and Drug Administration.
Christopher J Miller, Warren B Bilker, Ian DeLorey, Charles E Argoff, Russell L Bell

Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of acute pain in the U.S. in the wake of the opioid crisis.
James C Hackworth, John E Schneider, Maggie Do Valle, David Fam, Charles Argoff

Front Pain Res (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of small fiber neuropathy in female sexual dysfunction.
Shreya Patel, Jessmehar Walia, Monali Ardeshna, Dharma Ayer, Charles Argoff

J Sex Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to full agonist opioids in enriched enrollment randomized withdrawal clinical trials: a participant-level data meta-analysis.
Andrew Conroy, Warren B Bilker, Ian DeLorey, Darina Chudnovskaya, Tara McWilliams, Charles E Argoff

Pain· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical analgesics for neuropathic pain: An Evidence-Informed guide for the practicing clinician.
Erin Lawson, Priyanka Singla, Jeremy Adler, Charles E Argoff, Jeffrey J Bettinger

Pain Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
H Henry Lai, Michel A Pontari, Charles E Argoff, Larissa Bresler, Benjamin N Breyer

J Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain.
H Henry Lai, Michel A Pontari, Charles E Argoff, Larissa Bresler, Benjamin N Breyer

J Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.
H Henry Lai, Michel A Pontari, Charles E Argoff, Larissa Bresler, Benjamin N Breyer

J Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of successful initiation of buprenorphine in enriched enrollment randomized withdrawal clinical trials in both opioid experienced and naïve participants: a participant-level meta-analysis.
Andrew Conroy, Warren B Bilker, Christopher J Miller, Charles E Argoff, Russell Bell

Pain Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Common Is Pain in Neurologic Disorders and Why Should Neurologists Care?
Priyanka Singla, Charles E Argoff

Neurol Clin· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Future of Pain Management.
Pravarakhya Puppalla, Tara Menon Pattilachan, Rodrigo Salmeron de Toledo Aguiar, Charles E Argoff, Julie G Pilitsis

Neurol Clin· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Management and the Neurologist.
Charles E Argoff

Neurol Clin· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review.
Lynn Webster, Jeff Gudin, Jody L Green, Charles E Argoff

J Pain Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notable concerns in methodology and conclusions of the Wang et al. Meta-analysis in BMJ by the American Academy of Pain Medicine.
Nathaniel M Schuster, Mustafa Broachwala, Farshad M Ahadian, Charles E Argoff, Steven P Cohen

Pain Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based patient-centered pain management and the American Academy of Pain Medicine.
Charles E Argoff

Pain Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employer Perspective on Pain Fellowship Education: A Survey to Understand the Current State of Pain Medicine Training.
Sayed E Wahezi, Ugur Yener, Tahereh Naeimi, Heejung Choi, Yashar Eshraghi, Charles Argoff

J Pain Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy.
Erika A Petersen, Thomas G Stauss, James A Scowcroft, Michael J Jaasma, Deborah R Edgar, Charles E Argoff

J Diabetes Sci Technol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Neuropathic Pain.
Charles E Argoff

Continuum (Minneap Minn)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Collapse of Pain Medicine Using the Economic Recession of 2008 as a Comparator: Lessons Remain Unlearned.
Sayed E Wahezi, Corey W Hunter, Farshad M Ahadian, Charles E Argoff, Michael E Schatman

J Pain Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study.
Charles Argoff, Steven P Herzog, Ryan M Smith, Sameer V Kotak, Liza Sopina

J Headache Pain· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis